Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus for NF1-associated Low Grade Gliomas
NCT01158651Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jul 2010
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in glioma, sponsored by University of Alabama at Birmingham. Started Jul 2010; status: completed.
02
Drugs
everolimus
03
Conditions
glioma
Beyond the preview
Go deeper on NCT01158651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01158651.